Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // March 2nd, 2010 // 6:56 am
Good morning, everyone. Nice to see you again. We are hustling about this morning, attempting to hustle short people off to the schoolhouse. A worthy, if challenging, endeavor. Wish us luck. Meanwhile, another day beckons and so we present you the usual menu of interesting items to help you along. We hope your own day goes well. So dig in and persevere…
A Flood Of False-Mark Patent Lawsuits (Chicago Tribune)
Pfizer Layoffs May Yield A Tax Bill (St. Louis Post-Dispatch)
UCB Sees A Weaker 2010 (Reuters)
AstraZeneca Issues Online Communications Guidelines (press release)
Intercell Forecasts A Loss For The Year (Bloomberg)
FDA Panel Backs Bristol Transplant Drug (Reuters)
Philippines To Cut Prices On Nearly 100 Meds (PharmaTimes)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
AstraZeneca, Belatacept, Bristol Myers Squibb, Intercell, Internet Marketing, Layoffs, Online Marketing, Patents, Pfizer, UCB